Natixis Merit Medical Systems Inc Transaction History

Natixis

$20.7 Billion
Q3 2025

A detailed history of Natixis transactions in Merit Medical Systems Inc stock. As of the latest transaction made, Natixis holds 66,400 shares of MMSI stock, worth $5.65 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

66,400

Previous 14 474185.71%

Holding current value

$5.65 Million

Previous $1,000 552500.0%

% of portfolio

0.03%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$80.06 - $96.01 $5.31 Million - $6.37 Million	66,386 Added 474185.72%	66,400 $5.53 Million
Q1 2025 May 14, 2025	SELL	$95.64 - $110.29 $19,319 - $22,278	-202 Reduced 93.52%	14 $1,000
Q4 2024 Feb 13, 2025	SELL	$93.76 - $105.52 $19,595 - $22,053	-209 Reduced 49.18%	216 $20,000
Q3 2024 Nov 13, 2024	BUY	$84.12 - $100.23 $35,666 - $42,497	424 Added 42400.0%	425 $41,000
Q4 2023 Feb 13, 2024	SELL	$62.92 - $76.7 $23,720 - $28,915	-377 Reduced 99.74%	1 $0

Q3 2023 Nov 14, 2023	SELL	$63.36 - $84.73 $10,010 - $13,387	-158 Reduced 29.48%	378 $26,000
Q2 2023 Aug 11, 2023	BUY	$74.03 - $85.24 $39,680 - $45,688	536 New	536 $44,000
Q4 2020 Feb 12, 2021	SELL	$42.16 - $58.11 $197,308 - $271,954	-4,680 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$28.84 - $45.65 $134,971 - $213,642	4,680 New	4,680 $214,000
Q4 2018 Feb 14, 2019	SELL	$50.15 - $65.94 $192,224 - $252,748	-3,833 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$53.0 - $62.85 $203,149 - $240,904	3,833 New	3,833 $236,000
Q4 2017 Feb 14, 2018	SELL	$36.8 - $45.4 $253,662 - $312,942	-6,893 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$39.75 - $42.4 $273,996 - $292,263	6,893	6,893 $292,000

Others Institutions Holding MMSI

# of Institutions

422

Shares Held

96.2M

Call Options Held

911K

Put Options Held

25.3K

View Full List

About MERIT MEDICAL SYSTEMS INC

Ticker MMSI
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 56,919,400
Market Cap $4.84B
Description
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention produc...

More about MMSI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

News

Stay updated on Natixis with notifications on news.

Account